135 related articles for article (PubMed ID: 36863566)
21. New Oral Anticoagulants for Thromboprophylaxis in Patients with Cancer Receiving Chemotherapy: An Economic Evaluation in a Chinese Setting.
Du J; Wu B
Clin Drug Investig; 2020 Jul; 40(7):653-663. PubMed ID: 32445169
[TBL] [Abstract][Full Text] [Related]
22. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD004318. PubMed ID: 30916777
[TBL] [Abstract][Full Text] [Related]
23. Comparative Performance of Clinical Risk Assessment Models for Hospital-Acquired Venous Thromboembolism in Medical Patients.
Blondon M; Spirk D; Kucher N; Aujesky D; Hayoz D; Beer JH; Husmann M; Frauchiger B; Korte W; Wuillemin WA; Bounameaux H; Righini M; Nendaz M
Thromb Haemost; 2018 Jan; 118(1):82-89. PubMed ID: 29304528
[TBL] [Abstract][Full Text] [Related]
24. Thromboembolism prophylaxis in medical inpatients: effect on outcomes and costs.
Baser O; Sengupta N; Dysinger A; Wang L
Am J Manag Care; 2012 Jun; 18(6):294-302. PubMed ID: 22774997
[TBL] [Abstract][Full Text] [Related]
25. Considerations for pharmacologic thromboprophylaxis following inpatient brachytherapy for gynecologic malignancies.
McAlarnen LA; Small C; Tostrud L; Pan AY; Erickson B; Bedi M; Bradley WH
Brachytherapy; 2023; 22(5):630-639. PubMed ID: 37394350
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness analysis of doctor-pharmacist collaborative prescribing for venous thromboembolism in high risk surgical patients.
Hale A; Merlo G; Nissen L; Coombes I; Graves N
BMC Health Serv Res; 2018 Oct; 18(1):749. PubMed ID: 30285744
[TBL] [Abstract][Full Text] [Related]
27. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD004318. PubMed ID: 30481366
[TBL] [Abstract][Full Text] [Related]
28. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD004318. PubMed ID: 31449321
[TBL] [Abstract][Full Text] [Related]
29. Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study.
Paciullo F; Bury L; Noris P; Falcinelli E; Melazzini F; Orsini S; Zaninetti C; Abdul-Kadir R; Obeng-Tuudah D; Heller PG; Glembotsky AC; Fabris F; Rivera J; Lozano ML; Butta N; Favier R; Cid AR; Fouassier M; Podda GM; Santoro C; Grandone E; Henskens Y; Nurden P; Zieger B; Cuker A; Devreese K; Tosetto A; De Candia E; Dupuis A; Miyazaki K; Othman M; Gresele P
Haematologica; 2020 Jul; 105(7):1948-1956. PubMed ID: 31558677
[TBL] [Abstract][Full Text] [Related]
30. Estimating the value of future research into thromboprophylaxis for women during pregnancy and after delivery: a value of information analysis.
Davis S; Pandor A; Sampson FC; Hamilton J; Nelson-Piercy C; Hunt BJ; Daru J; Goodacre S
J Thromb Haemost; 2024 Apr; 22(4):1105-1116. PubMed ID: 38215911
[TBL] [Abstract][Full Text] [Related]
31. Is extended thromboprophylaxis necessary in elective colorectal cancer surgery?
Chandra R; Melino G; Thomas M; Lawrence MJ; Hunter RA; Moore J
ANZ J Surg; 2013 Dec; 83(12):968-72. PubMed ID: 23802729
[TBL] [Abstract][Full Text] [Related]
32. Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment.
Darzi AJ; Karam SG; Spencer FA; Spyropoulos AC; Mbuagbaw L; Woller SC; Zakai NA; Streiff MB; Gould MK; Cushman M; Charide R; Etxeandia-Ikobaltzeta I; Germini F; Rigoni M; Agarwal A; Morsi RZ; Akl EA; Iorio A; Schünemann HJ
Blood Adv; 2020 Jun; 4(12):2557-2566. PubMed ID: 32542391
[TBL] [Abstract][Full Text] [Related]
33. Swiss results from a global observational study of venous thromboembolism risk and prophylaxis use in the acute care hospital setting: analysis from the ENDORSE study.
Chopard P; Spirk D; Beer HJ; Peter J; Brunner B; Bounameaux H; Dörfller-Melly J
Swiss Med Wkly; 2009 Oct; 139(43-44):630-5. PubMed ID: 19950025
[TBL] [Abstract][Full Text] [Related]
34. Venous thromboembolism in benign esophageal surgery patients: potential cost effectiveness of Caprini risk stratification.
Perez SA; Reddy SB; Meister A; Pinjic E; Suzuki K; Litle VR
Surg Endosc; 2022 Jan; 36(1):764-770. PubMed ID: 33492505
[TBL] [Abstract][Full Text] [Related]
35. The additional benefit of graduated compression stockings to pharmacologic thromboprophylaxis in the prevention of venous thromboembolism in surgical inpatients.
Mandavia R; Shalhoub J; Head K; Davies AH
J Vasc Surg Venous Lymphat Disord; 2015 Oct; 3(4):447-455.e1. PubMed ID: 26992625
[TBL] [Abstract][Full Text] [Related]
36. Venous thromboembolism risk and prophylaxis prescription in surgical patients at a tertiary hospital in Eastern Cape Province, South Africa.
Rocher WD; Page T; Rocher M; Nel D
S Afr Med J; 2019 Feb; 109(3):178-181. PubMed ID: 30834875
[TBL] [Abstract][Full Text] [Related]
37. Stratification of venous thromboembolism risk in burn patients by Caprini score.
Li Q; Ba T; Wang LF; Chen Q; Li F; Xue Y
Burns; 2019 Feb; 45(1):140-145. PubMed ID: 30253959
[TBL] [Abstract][Full Text] [Related]
38. Performance of Risk Assessment Models for Peripartum Thromboprophylaxis.
Tran JP; Stribling SS; Ibezim UC; Omere C; McEnery KA; Pacheco LD; Hankins GD; Saade GR; Saad AF
Reprod Sci; 2019 Sep; 26(9):1243-1248. PubMed ID: 30486735
[TBL] [Abstract][Full Text] [Related]
39. Comparison between the Khorana prediction score and Caprini risk assessment models for assessing the risk of venous thromboembolism in hospitalized patients with cancer: a retrospective case control study.
Hu Y; Li X; Zhou H; Lin P; Zhang J; Huang D; Qi M; Tang Y; Yi Q; Liang Z; Wang M
Interact Cardiovasc Thorac Surg; 2020 Oct; 31(4):454-460. PubMed ID: 32910201
[TBL] [Abstract][Full Text] [Related]
40. Extended dalteparin prophylaxis for venous thromboembolic events: cost-utility analysis in patients undergoing major orthopedic surgery.
Dranitsaris G; Stumpo C; Smith R; Bartle W
Am J Cardiovasc Drugs; 2009; 9(1):45-58. PubMed ID: 19178131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
